The Forum of Private Business has attacked the pharmaceutical company over changes to the way it pays suppliers, but GlaxoSmithKline says most vendors would see “little to no impact”.
-
Recent Posts
Recent Comments
Archives
Categories
- 2004
- 2005
- 2006
- 2007
- 2008
- 2009
- 2010
- 2011
- 2012
- 2013
- Analysis
- Angeline Albert
- Ascertain
- Australia
- Business change
- Business change
- Careers
- cat-news
- Central government
- CIPS SM Awards
- Contact
- Ed's choice business change
- Ed's choice careers
- Ed's choice international
- Ed's choice low cost sourcing
- Ed's choice outsourcing
- Ed's choice public sector
- Ed's choice purchasing
- Ed's choice risk & continuity
- Ed's choice Southern Africa
- Ed's choice SRM
- Ed's choice supply chain
- Ed's choice sustainability
- Ed's choice technology
- Ed's choice travel
- Features
- Fraud & corruption
- Headline News
- home
- Home page picture story
- Home page top story
- International
- Intro business change
- Intro fraud & corruption
- Jake Kanter
- Law
- Law analysis
- Local government
- Low cost sourcing
- Main sections
- Maintain
- News
- News focus
- Opinion
- Outsourcing
- Paid for photos
- Partners
- Paul Snell
- People
- Placement
- PMI reports
- Public sector
- Purchasing
- Realise
- Rebecca Ellinor
- Recession & economic downturn
- Resources
- Risk & continuity
- Sectors
- Services
- SM 100
- Southern Africa
- SRM
- Supply chain
- Sustainability
- Technology
- TEST
- Topics
- Travel
- Uncategorized
- Why Us
- Year
Meta
